Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Innovative Biomarkers of Systemic Inflammation in LONG COVID Patients

NCT05672602 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.

NCT NCT05672602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Innovative Biomarkers of Systemic Inflammation in LONG COVID Patients
Lead sponsor
IRCCS Policlinico S. Donato
Phase
Observational
Overall status
Completed
Start date
July 20, 2022
Completion date
January 31, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid